Poolbeg Pharma PLC (POLBF)
USD 0.15
(27.97%)
USD 0.15
(27.97%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -26 Thousand GBP | 0.0% |
| 2022 | -26 Thousand GBP | -44.44% |
| 2021 | -18 Thousand GBP | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | -13 Thousand GBP | 0.0% |
| 2023 FY | -26 Thousand GBP | 0.0% |
| 2023 Q4 | -13 Thousand GBP | 0.0% |
| 2023 Q3 | - GBP | 100.0% |
| 2023 Q1 | - GBP | 100.0% |
| 2022 Q2 | -13 Thousand GBP | 0.0% |
| 2022 FY | -26 Thousand GBP | -44.44% |
| 2022 Q4 | -13 Thousand GBP | 0.0% |
| 2022 Q3 | - GBP | 100.0% |
| 2022 Q1 | - GBP | 0.0% |
| 2021 FY | -18 Thousand GBP | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bioxytran, Inc. | -8285.00 USD | -213.82% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 100.173% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 100.265% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 139.557% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 100.222% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.022% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 23.865% |
| Marizyme, Inc. | 457.7 Thousand USD | 105.681% |
| Genus plc | 178.7 Million USD | 100.015% |
| Pharming Group N.V. | 220.1 Million USD | 100.012% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 141.783% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 106.339% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -136.364% |
| ContraFect Corporation | -154 Thousand USD | 83.117% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 133.871% |
| IMV Inc. | -962.29 Thousand USD | 97.298% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 93.29% |
| ONE Bio Corp. | 20.12 Million USD | 100.129% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 100.065% |
| Mesoblast Limited | -35.16 Million USD | 99.926% |
| MultiCell Technologies, Inc. | 49.32 USD | 52816.951% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 100.092% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.006% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 938.169% |
| Biomind Labs Inc. | -15.42 Thousand USD | -68.568% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 97.722% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 137.143% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 79.075% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -425.04% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 48.0% |
| Arch Therapeutics, Inc. | -2439.00 USD | -966.011% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 118.505% |
| Accustem Sciences Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 153.17% |
| Q BioMed Inc. | -8988.00 USD | -189.275% |
| GB Sciences, Inc. | -624.00 USD | -4066.667% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 69.777% |
| CSL Limited | 7.56 Billion USD | 100.0% |
| Agentix Corp. | - USD | Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 100.059% |
| Enzolytics Inc. | 30.7 Thousand USD | 184.668% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 105.389% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 73.337% |
| argenx SE | 1.1 Billion USD | 100.002% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 99.899% |
| HST Global, Inc. | - USD | Infinity% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -12400.0% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 94.947% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| Zenith Capital Corp. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -193.586% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 104.211% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 68.992% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 102.632% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 100.271% |
| Kadimastem Ltd | -630.13 Thousand USD | 95.874% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | 15.42 Million USD | 100.169% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -119.687% |
| Cell Source, Inc. | - USD | Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 46.124% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 114.726% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 114.726% |
| Affymax, Inc. | 1.35 Million USD | 101.916% |
| Mobile Lads Corp. | - USD | Infinity% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 100.564% |
| CytoDyn Inc. | -29 Thousand USD | 10.345% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Qrons Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 105.777% |
| SYBLEU INC | 11.69 Thousand USD | 322.298% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 91.862% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 93.029% |
| Neutra Corp. | 14.33 Thousand USD | 281.374% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 68.293% |
| PureTech Health plc | -1.6 Million USD | 98.378% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 97.403% |
| IXICO plc | 3.27 Million USD | 100.795% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 96.254% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 98.548% |
| CSL Limited | 7.7 Billion USD | 100.0% |
| Cellectis S.A. | 18 Thousand USD | 244.444% |